| Identification | More | [Name]
1-MONOLINOLEIN | [CAS]
2277-28-3 | [Synonyms]
1-([CIS,CIS]-9,12-OCTADECADIENOYL)-RAC-GLYCEROL
1-LINOLEOYL-RAC-GLYCEROL
1-MONO[(CIS,CIS)-9,12-OCTADECADIENOYL]-RAC-GLYCEROL
1-MONOLINOLEIN
1-MONOLINOLEOYL-RAC-GLYCEROL
DELTA 9 CIS, 12 CIS MONOLINOLEIN
DELTA 9 TRANS, 12 TRANS MONOLINOELAIDIN
MONOLINOELAIDIN
MONOLINOLEIN
1-monolinoleoyl-rac-glycerol*(c18:2,(cis,cis)-9,1
2,3-dihydroxypropyl (9Z,12Z)-octadeca-9,12-dienoate
GLYCERYL LINOLEATE
1-MONOLINOLEOYL-RAC-GLYCEROL*(C18:2,(CIS ,CIS)-9,12)
9,12-Octadecadienoic acid (9Z,12Z)-, 2,3-dihydroxypropyl ester
2,3-Dihydroxypropyl 9,12-octadecadienoate
2,3-Dihydroxypropyl-(9Z,12Z)-octadeca-9,12-dienoat
[(2S)-2,3-dihydroxypropyl] (9Z,12Z)-octadeca-9,12-dienoate
1-MONOLINOLEOYL-RAC-GLYCEROL 99%
1-Monolinolein, 1-([cis,cis]-9,12-octadecadienoyl)-rac-glycerol
(-)-1-O-Linoleoyl-D-glycerol | [EINECS(EC#)]
218-901-4 | [Molecular Formula]
C21H38O4 | [MDL Number]
MFCD00056654 | [Molecular Weight]
354.52 | [MOL File]
2277-28-3.mol |
| Chemical Properties | Back Directory | [Appearance]
Colourless Oil | [Melting point ]
14-15 °C | [Boiling point ]
485.0±40.0 °C(Predicted) | [density ]
0.981±0.06 g/cm3(Predicted) | [storage temp. ]
−20°C
| [solubility ]
Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) | [form ]
liquid
| [pka]
13.16±0.20(Predicted) | [color ]
Colourless to Pale Yellow | [Stability:]
Light Sensitive, Temperature Sensitive | [LogP]
6.273 (est) | [Uses]
glyceryl linoleate is an emollient with moisturizing capabilities. It is synthetically produced from naturally derived ingredients. | [CAS DataBase Reference]
2277-28-3(CAS DataBase Reference) |
| Hazard Information | Back Directory | [Chemical Properties]
Colourless Oil | [Definition]
ChEBI: 1-monolinolein is a 1-monoglyceride that has octadecadienoyl (linoleoyl) as the acyl group. It has a role as a plant metabolite and an antiviral agent. It is functionally related to a linoleic acid. | [Biochem/physiol Actions]
Monolinolein (1-Linoleoyl-rac-glycerol) is used in the development of pH-responsive lyotropic liquid crystals for controlled drug delivery. |
|
|